<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><description>乘之愈往，识之愈真。如将不尽，与古为新。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 11 Mar 2021 11:14:51 +0800</pubDate><image><url>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</url><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>国内首个：恒瑞医药Aβ抗体获批临床，治疗阿尔茨海默症</title><link>https://mp.weixin.qq.com/s/Ohd7Ua5I8zABTZd7dTKtRw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAzkCiaxMyptqO2rHIjLuu8QDUTePOwhZknSzG1fxCKlKuGYnxxST3M1pJyREQ2c70oicwzwBJghePw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>SHR-1707]]></content:encoded><pubDate>Thu, 11 Mar 2021 08:58:25 +0800</pubDate></item><item><title>天境生物引进穿膜抗体技术：Alphabody</title><link>https://mp.weixin.qq.com/s/4bDBOvXF2AZnZr_C_7jeiw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAzkCiaxMyptqO2rHIjLuu8QopRzbO45j5tEGHyHuccPJVXOHUibMuSUicPQqqZMibUNVHOFaFLvrp2hw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3个α螺旋]]></content:encoded><pubDate>Thu, 11 Mar 2021 08:58:25 +0800</pubDate></item><item><title>CD3双抗靶向TCR，治疗T细胞淋巴瘤</title><link>https://mp.weixin.qq.com/s/_-Qw46mEWvmUUAECRGiqIg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAicqgGoLty0xJoicSg74HSwKWWibSqoxTWn0hrhm9sJJGZoLKYhFvrchn5DGFkllBU2cJNV11zztfXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>TCR β特异性双抗]]></content:encoded><pubDate>Thu, 11 Mar 2021 08:58:25 +0800</pubDate></item><item><title>2020年降糖药畅销排行榜</title><link>https://mp.weixin.qq.com/s/Y-P9lH6KVYI5aYNihuIzRg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAicqgGoLty0xJoicSg74HSwKeJrmbjYjGXuOAQibLPQYlXlcrFLDUBBpY4BoOnOZLSBibyRP7k4dug9g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>度拉糖肽占据榜首]]></content:encoded><pubDate>Thu, 11 Mar 2021 08:58:25 +0800</pubDate></item><item><title>2020年全球糖尿病市场研究报告</title><link>https://mp.weixin.qq.com/s/q1QGFie3wF1DWJIwvHpNOQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAzkCiaxMyptqO2rHIjLuu8Qic8qtmp30dicuM5lQz8dcfE0QpFayMicYbWrx8gOkblyhj91kUuJALyqA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>▎Armstrong2020年全球糖尿病市场规模超过520亿美元，相比2019年增幅2.3%。从降糖药类别来]]></content:encoded><pubDate>Wed, 10 Mar 2021 11:49:00 +0800</pubDate></item><item><title>泰它西普获批，疗效怎么样</title><link>https://mp.weixin.qq.com/s/Oy9zuAN8JHsQ0Bus--2kTA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAzkCiaxMyptqO2rHIjLuu8QqqlylL81H1nGcByfrj2FLV3NknQ30vxXX3PGaBYzddK3Ej4QMwjViaA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>泰它西普、Atacicept]]></content:encoded><pubDate>Wed, 10 Mar 2021 11:49:00 +0800</pubDate></item><item><title>石药集团2亿元入股倍而达，获得三代EGFR-TKI</title><link>https://mp.weixin.qq.com/s/L9eJKRavJWf2L5SUbMTkvg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNAzkCiaxMyptqO2rHIjLuu8Q2T7AOoudbm2vxoQDibaxqWBsUoTca88BDeddOkqhQd8VLsmg0FKU8qg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>EGFR-TKI和CDK4/6]]></content:encoded><pubDate>Wed, 10 Mar 2021 11:49:00 +0800</pubDate></item><item><title>IL-36R二期临床失败，AnaptysBio股价大跌36%</title><link>https://mp.weixin.qq.com/s/-Y_Dm050AuNwbT6m_WDtaA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTviaQSIMicicEyEC1MGgDwic40fibqX1VPtDNRJWnbIpIG1GfNYF0UQEIcJ05Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IL-36R]]></content:encoded><pubDate>Tue, 09 Mar 2021 07:23:13 +0800</pubDate></item><item><title>Silverback新型ADC</title><link>https://mp.weixin.qq.com/s/R8DnD7ZRYg0_eCGQcWS8Yw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTviaZxicu1hjib6Mnrwgg9P9zU40UZJyySDiaFUYWAxPCGnn2eibqaoXL9PfpQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>偶联：TLR8激动剂、TGFβR抑制剂]]></content:encoded><pubDate>Tue, 09 Mar 2021 07:23:13 +0800</pubDate></item><item><title>CureVac与特斯拉合作开发mRNA“打印机”</title><link>https://mp.weixin.qq.com/s/mKcHQ0GlrRWwipdkHCQ9gw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTviapoD4ZHkzic8YuW9Co0hmW2p6CneKwxU3MGMeYn65taCrlicmrx4HycGw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>制造个性化mRNA药物]]></content:encoded><pubDate>Tue, 09 Mar 2021 07:23:13 +0800</pubDate></item><item><title>阿斯利康Imfinzi之后，罗氏Tecentriq也撤回尿路上皮癌适应症</title><link>https://mp.weixin.qq.com/s/MIp3P9pBW_oIh8hnKsStSA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTvia926wpPBp46vHndFicSqicSQBiaj9vqCmNYGmXz39cfGM6RhuXAJwA8TcA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PD-L1]]></content:encoded><pubDate>Tue, 09 Mar 2021 07:23:13 +0800</pubDate></item><item><title>新冠南非和英国突变株，对多数中和抗体产生抵抗</title><link>https://mp.weixin.qq.com/s/PpHTpL14QB4lG-eF4y5JhQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTviaexnicghqAGnsLnXgZS6F2qYkIloOmtbqz2S9nVVLD9ibNVdM4Wbfl7qg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Vir、腾盛博药的中和抗体对南非突变株仍有效]]></content:encoded><pubDate>Tue, 09 Mar 2021 07:23:13 +0800</pubDate></item><item><title>中国ADC技术全梳理</title><link>https://mp.weixin.qq.com/s/l_gusNEy6FQQc4IpjuesWg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBj7K7LWib1fdrib9CibXyHTviaekP1zWMcibt6GY2gHMR6eXOAppnm0TryicaLeNDdSCyWPqO6R1cbjFibg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ADC]]></content:encoded><pubDate>Mon, 08 Mar 2021 11:32:12 +0800</pubDate></item><item><title>Moderna启动南非突变株新冠疫苗的临床试验</title><link>https://mp.weixin.qq.com/s/7Jl9mSRdpATtuA5R_5zUyQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBBlhuWeaicoZr08ogyl7Pz65HVUmRHLrtWeDMIzicBc1sEvdZ3w3dZiaibLbKibZgbkMloy650uQvicAibA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>mRNA1273.351]]></content:encoded><pubDate>Sun, 07 Mar 2021 07:55:39 +0800</pubDate></item><item><title>肿瘤免疫治疗的炎症性副作用</title><link>https://mp.weixin.qq.com/s/UmDorgB-0M0CQulLvzRA2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBBlhuWeaicoZr08ogyl7Pz6iaDpiaxiaRxfXxg24uGbCanGaebdGvDDXS1amzq6oQj4O1oWZUiaIIyNXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CTLA-4、PD-1、CAR-T]]></content:encoded><pubDate>Sat, 06 Mar 2021 14:34:34 +0800</pubDate></item><item><title>国内第2家：百奥赛图申报CD40抗体</title><link>https://mp.weixin.qq.com/s/N5jtL6T2hxJ7BlrasScmHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBBlhuWeaicoZr08ogyl7Pz6WkBoGPNB9yGibtKdaibicQkl04FicgO08VJhERl1ScZGrBwTkkNfyM2ELA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CD40]]></content:encoded><pubDate>Sat, 06 Mar 2021 14:34:34 +0800</pubDate></item><item><title>双抗：靶向肿瘤新抗原</title><link>https://mp.weixin.qq.com/s/x1rl305jarNVsLMvfzSutA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBAUJQ3AZDGibcLvTJicd7sfVfiaF68iaCXuzQlibqaeoPJmaVg9QxYY8e4nt1hFjKjRticzHicFcRCPnp3w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>靶向MHC-peptide复合物]]></content:encoded><pubDate>Fri, 05 Mar 2021 22:33:50 +0800</pubDate></item><item><title>信达生物申报第6款双抗：IBI321</title><link>https://mp.weixin.qq.com/s/Vra1FK8sbIZnitlTNeVN3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCp8quYlDswOcnic7icTtic4Lzaqxtw2JYEXwicHOcJ0nhdNic85DJw7XGn4m1qQgywrXwlxsCLHoD2yIQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PD--1/未公开靶点]]></content:encoded><pubDate>Thu, 04 Mar 2021 15:11:18 +0800</pubDate></item><item><title>乐普生物申报溶瘤病毒：CG0070</title><link>https://mp.weixin.qq.com/s/feqCmVv9-ABJVgDjW9CLMg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCp8quYlDswOcnic7icTtic4LzJic0PalRQDibDgCCQAzX5sh3BurK4bTqLhaGqEicy2HMK2n0cywdPmp1w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>腺病毒5]]></content:encoded><pubDate>Thu, 04 Mar 2021 15:11:18 +0800</pubDate></item><item><title>挑战K药一线NSCLC地位：百济神州启动PD-1+TIGIT的国际多中心三期临床</title><link>https://mp.weixin.qq.com/s/5pSMMFXxBMiAdFxgdMtsBQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDWGwTbQguUvPvJUaXHYpFMet8icq7CJXyG1JzkzHiauOTN0lIa0fJwjdbataxPfMhYE13MIKOnRsWQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>挑战王者]]></content:encoded><pubDate>Wed, 03 Mar 2021 11:13:36 +0800</pubDate></item></channel></rss>